<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7034">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03015350</url>
  </required_header>
  <id_info>
    <org_study_id>One lung ventilation</org_study_id>
    <nct_id>NCT03015350</nct_id>
  </id_info>
  <brief_title>Blood Levels of Sevoflurane and Desflurane</brief_title>
  <official_title>Blood Levels of Sevoflurane and Desflurane During One Lung Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      16 patients with American Society of AnesthesioIogy (ASA) physical status I-III will
      recruited to this study. Patients will divided to the 2 groups. %1.5 Sevoflurane will apply
      in Group S and %6 Desflurane will apply in Group D. Each groups will divide 2 subgroups. Two
      lung ventilation will be performed to Group Sa and Group Da, one lung ventilation will be
      performed to Group Sb and Group Db. At the time point 40.minutes first blood sample will
      given from patients. Blood sample will be taken at intervals of 10 minutes from groups of
      two lung ventilation. In groups of one lung ventilation, blood samples will be taken at the
      time interval of 10 minutes after one lung ventilation started. All blood samples will be
      assess in Gas Chromatography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigator aimed to assess blood level of sevoflurane and desflurane during two lung
      ventilation and one lung ventilation. The investigators will use Gas Chromatography for
      define drugs levels. 16 patients with ASA I-III patients who undergo thoracotomy and
      abdominal surgery will be recruited to this study. Patients will divided in to the 2 groups.
      %1.5 Sevoflurane will apply in Group S and %6 Desflurane will apply in Group D during
      anesthesia maintenance. Each groups will divide 2 subgroups which are one lung ventilation
      groups and two lung ventilation groups. Two lung ventilation will be performed to Group Sa
      and Group Da, one lung ventilation will be performed to Group Sb and Group Db. Sequential
      blood samples will be taken from both arterial and central venous canula at the same time
      point. First blood samples will be taken at 40. minutes of anesthesia. Sequential samples
      will be taken at interval of 10 minutes during two lung ventilation. In one lung ventilation
      second blood samples will be taken at the 10. minutes of one lung ventilation. After than at
      the interval of 10 minutes, collection of blood samples both arterial and central venous
      will be continue.

      All collection will assess with gas chromatography.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of blood levels of Sevoflurane and Desflurane</measure>
    <time_frame>from 40th minute to the end of the operation</time_frame>
    <description>Data collections will be ensured from arterial and venous blood sample and than samples will be assessed with gas chromatography and blood sevoflurane and desflurane level will be measured. Blood samples will take every 10 minutes. Only blood levels of sevoflurane and desflurane will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determine of ventilation-perfusion mismatch with p(A-a)O2</measure>
    <time_frame>from 40th minute to the end of the one lung ventilation</time_frame>
    <description>During one lung ventilation, p(a-A)O2 will be assessed with arterial blood analyses</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Anesthetics, Inhalation</condition>
  <arm_group>
    <arm_group_label>two lung ventilation of Sevoflurane</arm_group_label>
    <description>In GroupSa, 1,5 % sevoflurane will be apply continuously and blood samples will be taken at intervals of 10 minutes starting from the 40th minute.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>one lung ventilation of Sevoflurane</arm_group_label>
    <description>In GroupSa, 1,5 % sevoflurane will be apply continuously and first samples will taken at the 40. minutes and collection of blood samples will be continue at intervals of 10 minutes after one lung ventilation started.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>two lung ventilation of Desflurane</arm_group_label>
    <description>In GroupSa, 6 % desflurane will be apply continuously and blood samples will be taken at intervals of 10 minutes starting from the 40th minute.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>one lung ventilation of desflurane</arm_group_label>
    <description>In GroupSa, 6 % desflurane will be apply continuously and first samples will taken at the 40. minutes and collection of blood samples will be continue at intervals of 10 minutes after one lung ventilation started.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Measurement of blood desflurane level during one lung ventilation</description>
    <arm_group_label>two lung ventilation of Sevoflurane</arm_group_label>
    <arm_group_label>one lung ventilation of Sevoflurane</arm_group_label>
    <other_name>Blood sevoflurane level</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Measurement of blood desflurane level during one lung ventilation</description>
    <arm_group_label>two lung ventilation of Desflurane</arm_group_label>
    <arm_group_label>one lung ventilation of desflurane</arm_group_label>
    <other_name>Blood desflurane level</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        16 patients with ASA I-III who undergo thoracotomy or abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: ASA I-II patients

          -  Who undergo thoracotomy or abdominal surgery

        Exclusion Criteria:

          -  ASA IV and up patients

          -  Patients who taken inotropic agent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Biricik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cukurova University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebru Biricik, MD</last_name>
    <phone>+905052420223</phone>
    <email>ebrubiricik@mynet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ã‡ukurova University</name>
      <address>
        <city>Adana Ili</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ebru Biricik, MD</last_name>
      <phone>+905052420223</phone>
      <email>ebrubiricik@mynet.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>March 31, 2017</lastchanged_date>
  <firstreceived_date>December 27, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>MD, Anesthesiology specialist</investigator_title>
  </responsible_party>
  <keyword>blood sevoflurane concentration</keyword>
  <keyword>blood desflurane concentration</keyword>
  <keyword>one lung ventilation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
